AZD 3965 

To Order Contact us: stephen@expresspharmapulse.com

GW-3965 hydrochloride
9402-25
EUR 675

GW-3965 hydrochloride
9402-5
EUR 207

MICROPLATE, STORAGE, 384 WELL, POLYPROPYLENE, 180 µL, CLEAR, SQUARE WELLS, ROUND BOTTOM, NOT TREATED, NO LID, NONSTERILE, BULK
3965 5/pk
EUR 614
Description: Storage; Storage Blocks - 384 Well

mmu-miR-3965 Primers
MPM02282 150 ul / 10 uM
EUR 121

AZD-5363
B1762-25
EUR 588

AZD-5363
B1762-5
EUR 185

AZD-4635
B2012-25
EUR 756

AZD-4635
B2012-5
EUR 229

AZD-5153
B2020-25
EUR 865

AZD-5153
B2020-5
EUR 262

AZD-5069
B2053-25
EUR 675

AZD-5069
B2053-5
EUR 207

AZD-5438
B2073-25
EUR 544

AZD-5438
B2073-5
EUR 175

AZD-5582
B2362-1
EUR 131

AZD-5582
B2362-5
EUR 370

AZD-3229
B2513-1
EUR 175

AZD-3229
B2513-5
EUR 512

AZD-5597
B5926-25 25 mg
EUR 1442
Description: AZD-5597 is a potent CDK inhibitor with IC50 values of 2 nM for CDK1 and CDK2, respectively [1].

AZD-5597
B5926-5 5 mg
EUR 456
Description: AZD-5597 is a potent CDK inhibitor with IC50 values of 2 nM for CDK1 and CDK2, respectively [1].

AZD-5597
B5926-5.1 10 mM (in 1mL DMSO)
EUR 618
Description: AZD-5597 is a potent CDK inhibitor with IC50 values of 2 nM for CDK1 and CDK2, respectively [1].

AZD-8186
B1027-25
EUR 756

AZD-8186
B1027-5
EUR 229

AZD-9291
B1104-10 10 mg
EUR 160
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR.

AZD-9291
B1104-5 5 mg
EUR 131
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR.

AZD-9291
B1104-5.1 10 mM (in 1mL DMSO)
EUR 154
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR.

AZD-9291
B1104-50 50 mg
EUR 340
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR.

AZD-9291
B1104-500 500 mg
EUR 1186
Description: AZD-9291 is an irreversible inhibitor of mutant EGFR with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR [1].A series of mutations cause the resistance of EGFR, AZD-9291 is developed for an irreversible and selective inhibitor of the mutant EGFR.

AZD-6482
B1143-25
EUR 675

AZD-6482
B1143-5
EUR 207

AZD-6738
B1167-25
EUR 588

AZD-0156
B1305-25
EUR 512

AZD 3988
B4944-10 10 mg
EUR 583

AZD 3988
B4944-50 50 mg
EUR 2225

AZD 5153
C3076-10 10 mg
EUR 383
Description: Target: BRD4IC50: 5 nMAZD5153 is a potent, selective, and orally available inhibitor of the bromodomain and extraterminal (BET) protein BRD4, with the IC50 value of 5 nM.

AZD 5153
C3076-25 25 mg
EUR 728
Description: Target: BRD4IC50: 5 nMAZD5153 is a potent, selective, and orally available inhibitor of the bromodomain and extraterminal (BET) protein BRD4, with the IC50 value of 5 nM.

AZD 5153
C3076-5 5 mg
EUR 248
Description: Target: BRD4IC50: 5 nMAZD5153 is a potent, selective, and orally available inhibitor of the bromodomain and extraterminal (BET) protein BRD4, with the IC50 value of 5 nM.

AZD-5438
HY-10012 10mg
EUR 133

AZD-5991
HY-101533 5mg
EUR 452

AZD-1480
HY-10193 5mg
EUR 119

AZD 6482
HY-10344 10mM/1mL
EUR 254

AZD-8055
HY-10422 200mg
EUR 505

AZD-7762
HY-10992 100mg
EUR 695

AZD 9272
HY-110254 5mg
EUR 142

AZD 2066
HY-110255 5mg
EUR 383

AZD-0364
HY-111483 50mg
EUR 2002

AZD-7648
HY-111783 10mg
EUR 223

AZD-5069
HY-19855 5mg
EUR 153

AZD-6280
HY-19872 20mg
EUR 3356

AZD-0284
HY-120384 100mg
EUR 3896

AZD-8835
HY-12869 25mg
EUR 337

AZD-2461
HY-13536 10mM/1mL
EUR 126

AZD-3463
HY-15609 100mg
EUR 782

AZD 4407
HY-U00217 10mg
EUR 3700

Azd-9291
abx183859-100mg 100 mg
EUR 676
  • Shipped within 1-2 weeks.

AZD-4547
9403-25
EUR 457

AZD-4547
9403-5
EUR 153

AZD-7762
9414-25
EUR 414

AZD-7762
9414-5
EUR 142

AZD-2014
9449-25
EUR 544

AZD-2014
9449-5
EUR 175

AZD-3759
9609-25
EUR 631

AZD-3759
9609-5
EUR 196

AZD-1981
9611-25
EUR 631

AZD-1981
9611-5
EUR 196

AZD-8931
9659-25
EUR 620

AZD-8931
9659-5
EUR 207

AZD-5438
A8326-10 10 mg
EUR 119
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively.

AZD-5438
A8326-100 100 mg
EUR 502
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively.

AZD-5438
A8326-5.1 10 mM (in 1mL DMSO)
EUR 125
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively.

AZD-5438
A8326-50 50 mg
EUR 305
Description: AZD5438 is a potent small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with half maximal inhibitory concentration IC50 of 16 nmol/L, 6 nmol/L and 20 nmol/L respectively.

AZD-3463
A8620-10 10 mg
EUR 224
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma.

AZD-3463
A8620-100 100 mg
EUR 667
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma.

AZD-3463
A8620-5 5 mg
EUR 160
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma.

AZD-3463
A8620-5.1 10 mM (in 1mL DMSO)
EUR 177
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma.

AZD-3463
A8620-50 50 mg
EUR 471
Description: Target: ALK, IGF1RIC50: 0.75 nM(Ki)AZD3463 is a novel orally bioavailable ALK/IGF1R inhibitor with Ki value of 0.75 nM. ALK expression is largely restricted to neurons and upregulated in neuroblastoma.

AZD-3463
2371-25
EUR 457

AZD-3463
2371-5
EUR 153

AZD 3965